Likewise, in the MDCa@RBC‐Alipo treatment group, significantly elevated levels of serum cytokines such as TNF‐α, IL‐6, and IL1‐β, which play crucial roles in cellular immunity against cancer, were observed (Figure 5L). Here, IL1B is linked to cancer.